Signal hints it could leave Canada over lawful access bill

Signal’s vice president of strategy said the firm “would rather pull out of the country” than…

Australia’s proposed CGT changes could discourage long-term crypto holding

Robin Singh, CEO and founder of Koinly said the changes will hurt low-income crypto investors most…

Kraken joins LayerZero exodus as it switches to Chainlink CCIP

LayerZero has come under scrutiny since it was exploited in April, as crypto protocols reevaluate their…

Strategy’s STRC hits record $1.5B trading volume

Strategy has leaned on Stretch to fund Bitcoin buys over the past 12 months as funding…

Bullish shares dip on Q1 earnings miss, $605M loss

Bullish stock dropped in trading with the crypto exchange’s first-quarter earnings miss, adding to the crypto…

Supertone Releases Supertonic v3: On-Device Text-to-Speech Model with 31-Language Support, Fewer Reading Failures, and Expression Tags

Supertone released Supertonic 3, the third generation of its on-device, ONNX-based text-to-speech system. Supertonic 3 ships…

How to Build a Django-Unfold Admin Dashboard with Custom Models, Filters, Actions, and KPIs

In this tutorial, we build an advanced Django-Unfold admin dashboard. We start by installing Django, Django-Unfold,…

Gemini reports 42% revenue growth after expansion into financial services

Gemini credit card revenue surged nearly 300% to $14.7 million in Q1, attributed to significant growth…

Crypto data company Dune cuts 25% of staff in restructuring

Dune co-founder and CEO Fredrik Haga says the company’s staff cuts come as it shifts focus…

New Stroke Study Challenges Decades-Old Medical Beliefs

Lacunar stroke may arise from damage in the brain’s small blood vessels rather than fatty plaque…

These Simple Plant Foods Are Linked to Lower Blood Pressure

Higher soy and legume intake may reduce the risk of high blood pressure, with the greatest…

Common Blood Pressure Drug Supercharges Cancer Treatment in Surprising New Study

A common blood pressure drug may help a major class of cancer therapies work far better…